Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for biopharmaceuticals
3.2.1.2 Growing investments for developing new biopharmaceuticals and biosimilars
3.2.1.3 Increasing regulatory approvals for biopharmaceutical products
3.2.1.4 Growing adoption of single use fermenters
3.2.2 Industry pitfalls & challenges
3.2.2.1 Requirements for high initial capital investments
3.2.2.2 Issues related to extractables and leachables
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Upstream products
5.2.1 Bioreactors/fermenters
5.2.2 Bioprocess analyzers
5.2.3 Process monitoring systems
5.2.4 Other upstream products
5.3 Downstream products
5.3.1 Filtration & separation
5.3.2 Chromatography
5.3.3 Consumables & accessories
5.3.4 Other downstream products
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Recombinant proteins
6.3 Antibiotics
6.4 Probiotics
6.5 Other applications
Chapter 7 Market Estimates and Forecast, By End User, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Biopharmaceutical companies
7.3 Contract research organizations
7.4 Academic research institutes
7.5 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Agilent Technologies, Inc.
9.2 Becton, Dickinson and Company
9.3 Bioengineering AG
9.4 Cellexus Limited
9.5 Danaher Corporation
9.6 Eppendorf AG
9.7 F. Hoffmann-La Roche Ltd.
9.8 GE HealthCare Technologies, Inc.
9.9 Getinge Group
9.10 Lonza Group AG
9.11 Merck KGaA
9.12 Nova Biomedicals
9.13 Sartorius Stedim Biotech
9.14 Thermo Fisher Scientific Inc.
9.15 ZETA
